Bicameral Amicus Brief Challenges FDA's Deregulation of Chemical Abortion Drugs
February 29, 2024
February 29, 2024
WASHINGTON, Feb. 29 -- Sen. Kevin Cramer, R-North Dakota, issued the following news release:
In less than a month, the Supreme Court of the United States is expected to hear arguments in Food and Drug Administration v. Alliance for Hippocratic Medicine, a case challenging the agency's deregulation of chemical abortion drugs in 2016 and 2021. According to the Guttmacher Institute, abortion medication accounted for 53% of all facility-based abortions in the United States in 2020. Prel . . .
In less than a month, the Supreme Court of the United States is expected to hear arguments in Food and Drug Administration v. Alliance for Hippocratic Medicine, a case challenging the agency's deregulation of chemical abortion drugs in 2016 and 2021. According to the Guttmacher Institute, abortion medication accounted for 53% of all facility-based abortions in the United States in 2020. Prel . . .